Company Filing History:
Years Active: 2013
Title: The Innovations of David Wone
Introduction
David Wone is an accomplished inventor based in Newark, California. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on alpha4 integrin antagonists. His research has the potential to impact the treatment of various gastrointestinal disorders.
Latest Patents
David Wone holds a patent for "Pyridinone antagonists of alpha-4 integrins." This invention provides compounds that act as alpha4 integrin antagonists, which are crucial in the treatment and prevention of conditions such as Crohn's disease and ulcerative colitis. The patent details the structure of these compounds and includes pharmaceutical compositions that utilize them.
Career Highlights
Wone is currently associated with Elan Pharmaceuticals, Inc., where he continues to advance his research in the pharmaceutical industry. His work has been instrumental in developing new therapeutic options for patients suffering from chronic conditions.
Collaborations
David Wone has collaborated with notable colleagues, including Ying-Zi Xu and Shendong Yuan. These partnerships have fostered a collaborative environment that enhances the innovation process within the company.
Conclusion
David Wone's contributions to the field of pharmaceuticals through his patent on alpha4 integrin antagonists exemplify the impact of innovative research on healthcare. His work continues to pave the way for new treatments that can improve the quality of life for many patients.